Monthly revenue and year-on-year change for LI Kang Biomedical (6242) and PEC (6446) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.
Year-on-year change
Monthly revenue history
| Month | LI Kang Biomedical | YoY | PEC | YoY |
|---|---|---|---|---|
| Oct 2026 | NT$53 million | -8.1% | NT$2.84 billion | +102.0% |
| Sep 2026 | NT$41.9 million | +7.6% | NT$2.64 billion | +100.0% |
| Aug 2026 | NT$37 million | -0.5% | NT$2.62 billion | +105.4% |
| Jul 2026 | NT$42.1 million | -0.1% | NT$2.51 billion | +92.6% |
| Jun 2026 | NT$49.9 million | -8.3% | NT$2.33 billion | +94.9% |
| May 2026 | NT$58 million | +7.9% | NT$2.46 billion | +108.5% |
| Apr 2026 | NT$54.1 million | -4.2% | NT$2.06 billion | +68.3% |
| Mar 2026 | NT$53.5 million | -7.9% | NT$1.94 billion | +64.4% |
| Feb 2026 | NT$24.4 million | -44.6% | NT$1.6 billion | +56.7% |
| Jan 2026 | NT$43.7 million | +33.6% | NT$1.58 billion | +49.8% |
| Dec 2025 | NT$54.8 million | +3.3% | NT$1.92 billion | +69.9% |
| Nov 2025 | NT$59.2 million | +10.2% | NT$1.55 billion | +53.0% |
| Oct 2025 | NT$57.6 million | +0.8% | NT$1.4 billion | +53.6% |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16